Serina Therapeutics Files 8-K with Regulatory Updates
Ticker: SER · Form: 8-K · Filed: Sep 5, 2024 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Sep 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K, disclosure
TL;DR
Serina Therapeutics (SRNA) filed an 8-K, check for material updates.
AI Summary
Serina Therapeutics, Inc. filed an 8-K on September 5, 2024, reporting events as of September 4, 2024. The filing is primarily a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as AgeX Therapeutics, Inc. until June 6, 2017, is incorporated in Delaware and headquartered in Huntsville, Alabama.
Why It Matters
This 8-K filing indicates Serina Therapeutics is providing updated information to the SEC, which could include material disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosure and exhibits, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- AgeX Therapeutics, Inc. (company) — Former company name
- September 4, 2024 (date) — Date of earliest event reported
- September 5, 2024 (date) — Filing date
- Huntsville, Alabama (location) — Principal executive offices location
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the header information.
What types of financial statements and exhibits are included?
The filing states that Financial Statements and Exhibits are included, but the specific nature of these documents is not detailed in the header.
When did the company change its name from AgeX Therapeutics, Inc.?
The company's name was changed from AgeX Therapeutics, Inc. on June 6, 2017.
Where are Serina Therapeutics' principal executive offices located?
The principal executive offices are located at 601 Genome Way, Suite 2001, Huntsville, Alabama 35806.
What is the SIC code for Serina Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Serina Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2024-09-04 20:03:22
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SER NYSE American Indic
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 6KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-035028.txt ( ) — 227KB
- ser-20240904.xsd (EX-101.SCH) — 3KB
- ser-20240904_lab.xml (EX-101.LAB) — 34KB
- ser-20240904_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERINA THERAPEUTICS, INC. Date: September 4, 2024 By: /s/ Steve Ledger Interim Chief Executive Officer